Microbiología y Parasitología

2018

1. A review of the antibacterial activity of ozenoxacin

   Future Microbiology

2. Correction to: Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey (European Journal of Clinical Microbiology & Infectious Diseases, (2018), 37, 9, (1611-1618), 10.1007/s10096-018-3264-0)

   European Journal of Clinical Microbiology and Infectious Diseases

3. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial

   Clinical Microbiology and Infection

4. Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria" (Antimicrobial Agents and Chemotherapy (2018) 62:9 (e00012-18) DOI: 10.1128/AAC.00012-18)

   Antimicrobial Agents and Chemotherapy

5. First isolation of Skermanella aerolata from a human sample

   Revista Espanola de Quimioterapia

6. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

   Journal of Antimicrobial Chemotherapy

7. Helminthosis and eosinophilia in Spain (1990-2015)

   Enfermedades Infecciosas y Microbiologia Clinica

8. Hot topics in necrotising skin and soft tissue infections

   International Journal of Antimicrobial Agents

9. Inonotosis in patient with hematologic malignancy

   Emerging Infectious Diseases

10. MIC-based dose adjustment: facts and fables-authors' response

    The Journal of antimicrobial chemotherapy

11. Severe bacterial non-AIDS infections in HIV women

    Revista Espanola de Quimioterapia

12. The role of echocardiography as a risk-stratification tool in infective endocarditis

    European Journal of Internal Medicine